Glasgow Prognostic Score in Patients Receiving Chemotherapy for Non-small-cell Lung Cancer in Stages IIIb and IV

INTRODUCTION: Lung cancer is most common cause of cancer-related mortality worldwide. Non-small-cell lung carcinoma (NSCLC) is disease with very low 5-year relative survival rate. For patients with non-small cell lung cancer, roles of current treatments are to prolong survival time and to improve qu...

Descripción completa

Detalles Bibliográficos
Autores principales: Umihanic, Sefika, Umihanic, Sekib, Jamakosmanovic, Sead, Brkic, Selmira, Osmic, Munevera, Dedic, Suvad, Ramic, Nusret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AVICENA, d.o.o., Sarajevo 2014
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272493/
https://www.ncbi.nlm.nih.gov/pubmed/24937927
http://dx.doi.org/10.5455/medarh.2014.68.83-85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272493/
https://www.ncbi.nlm.nih.gov/pubmed/24937927
http://dx.doi.org/10.5455/medarh.2014.68.83-85

Ejemplares similares